Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 1Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 412Thoracic 7Lymphoid 3Gastrointestinal 2Breast 2Sarcoma 1Gynecologic 1

Conditions

Colorectal Neoplasms 5925Pancreatic Neoplasms 3552Carcinoma, Hepatocellular 3264Stomach Neoplasms 3051Colonic Neoplasms 2326Rectal Neoplasms 2186Esophageal Neoplasms 1797Liver Neoplasms 1246Neoplasms 1179Breast Neoplasms 1062Neoplasm Metastasis 867Carcinoma, Non-Small-Cell Lung 789Lung Neoplasms 743Cholangiocarcinoma 737Gastrointestinal Neoplasms 661Ovarian Neoplasms 628Esophageal Squamous Cell Carcinoma 581Prostatic Neoplasms 483Melanoma 457Biliary Tract Neoplasms 438Head and Neck Neoplasms 376Uterine Cervical Neoplasms 342Carcinoma, Renal Cell 327Gastrointestinal Stromal Tumors 324Adenocarcinoma Of Esophagus 315Sarcoma 303Barrett Esophagus 300Anus Neoplasms 284Gallbladder Neoplasms 281Urinary Bladder Neoplasms 280

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Solid Tumor × Gastrointestinal × Clear all
NCT05076591 2024-10-30

IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Phase 1 Suspended
135 enrolled
BreastGastrointestinalOther solid neoplasm

Advanced Solid Tumor

NCT05805956 2023-04-10

IMM2902 in Patients With Advanced Solid Tumors Expressing HER2

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Phase 1/2 Unknown
105 enrolled
GastrointestinalOther solid neoplasmThoracic

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡